The Venture Codex

Participated · Equity · Aug 2026

Incorporated in 2000 and based in Goa, Molbio Diagnostics develops and manufactures the Truenat point-of-care PCR platform and test kits for molecular diagnosis across more than 30 diseases including tuberculosis, COVID, HIV, HPV and hepatitis B and C. Its battery-operated Truenat platform is patented in over 100 countries and is designed for deployment in resource-limited settings to enable decentralized diagnosis within an hour. The company operates six manufacturing facilities in India (two in Goa, two in Bengaluru, and one each in Visakhapatnam and Pune) with an installed capacity of 5,400 devices per annum and 3.9 crore Truenat test kits annually as of March 31, 2026. Financially, Molbio reported revenue from operations of ₹1,445 crore and profit of ₹164 crore for fiscal 2026. The company intends to expand R&D and manufacturing capacity using proceeds from its IPO, including funds earmarked for a Centre of Excellence, additional infrastructure and new plant and machinery. Its shares are proposed to be listed on the BSE and NSE on August 17, 2026.

Participated · Equity · Jan 2026

Founded in 2008, Amagi Media Labs provides cloud-based software that helps broadcasters and streaming platforms manage, distribute, and monetise video across smart TVs, smartphones, and other digital endpoints. The company operates three business lines—cloud modernisation, streaming unification, and monetisation & marketplace—and currently serves more than 45 % of India’s top-50 listed media and entertainment companies by revenue. Amagi booked ₹1,162 crore in revenue from operations in FY25, reflecting a 31 % CAGR between FY23 and FY25, and earned ₹6.40 crore in profit on ₹704.80 crore revenue during the six months ended 30 September 2025. At the upper end of its IPO price band, the firm is valued at over ₹7,800 crore. Management plans to deploy ₹550 crore of fresh capital to bolster technology and cloud infrastructure, pursue inorganic growth via acquisitions, and fund general corporate purposes over FY26-FY28.

Participated · Equity · Dec 2025

Founded in 2016, Wakefit has built a full-stack model that spans product design, in-house manufacturing, distribution, and customer engagement. Its portfolio covers mattresses, furniture, and home furnishings sold via its website, company-owned–company-operated (COCO) stores, and major e-commerce and multi-brand outlets. Wakefit operates five manufacturing facilities across Karnataka, Tamil Nadu, and Haryana that use imported machinery and automation to streamline production and reduce waste. For the six months ended 30 September 2025, the company generated ₹724 crore in revenue from operations and ₹35.5 crore in profit. Management plans to deploy fresh capital to open 117 new COCO stores, purchase new equipment, fund lease payments for existing outlets, and bolster marketing. The firm is preparing for a ₹1,289 crore IPO that would value it at roughly ₹6,400 crore. Wakefit’s growth trajectory positions it among the fastest Indian home-and-furnishings brands to surpass ₹1,000 crore in total income within the organised segment.

Participated · Equity · Dec 2025

Meesho operates a large-scale online marketplace that, in FY25, connected over 500,000 transacting sellers with 199 million annual transacting users who placed 1.8 billion orders. The platform generated Net Merchandise Value of ₹29,988 crore in FY25, reflecting 29 % year-on-year growth after a 21 % rise in FY24. While it reported a FY25 net loss of ₹3,942 crore due to one-time items tied to its public-listing restructure, losses narrowed sharply to ₹700.72 crore in the first half of FY26 as revenue rose to ₹5,577.54 crore. Meesho plans to channel fresh capital into cloud infrastructure, marketing and brand initiatives, and inorganic growth via acquisitions, alongside general corporate purposes. The company’s marketplace model focuses on low-cost, long-tail consumer goods, enabling micro-entrepreneurs to sell online. Backers include SoftBank, Elevation, Peak XV, Venture Highway and Y Combinator, several of whom will partially exit through the upcoming IPO. The business is preparing to debut on public markets on 10 December.

Participated · Equity · Oct 2025

Founded in 2007, Canara HSBC Life Insurance Company Ltd operates as a private, bank-promoted life insurer in India, offering term, savings, and other life insurance products primarily through the branch networks of its promoter banks. The company is a joint venture in which Canara Bank holds 51 %, HSBC Insurance (Asia-Pacific) Holdings owns 26 %, and Punjab National Bank is a minority shareholder. Over the years, the insurer has established itself as a significant player among private life insurance providers that leverage bancassurance distribution. To unlock shareholder liquidity, the firm is pursuing a public listing via a ₹2,516 crore initial public offering structured entirely as an offer for sale. Because the IPO is an OFS, the company itself will not receive primary capital; instead, proceeds will flow to the selling shareholders. Ahead of the IPO, the company allotted shares to anchor investors to bolster demand and provide pricing stability. Post-listing, Canara HSBC Life will gain enhanced public visibility and a broadened shareholder base, which management hopes will support future growth initiatives in India’s expanding life insurance market.